Home > Legislation > 115th Congress > H.R.1492

H.R.1492 - Medical Controlled Substances Transportation Act of 2017115th Congress (2017-2018) |

Bill

Hide Overview
Sponsor: Rep. Sessions, Pete [R-TX-32] (Introduced 03/10/2017)
Committees: House - Energy and Commerce; Judiciary | Senate - Judiciary
Committee Reports: H. Rept. 115-192
Latest Action: Senate - 07/13/2017 Received in the Senate and Read twice and referred to the Committee on the Judiciary.  (All Actions)
Roll Call Votes: There has been 1 roll call vote

Tracker:

This bill has the status Passed House

Here are the steps for Status of Legislation:

  1. Introduced
  2. Passed House
  3. Passed Senate
  4. To President
  5. Became Law

More on This Bill

  • Constitutional Authority Statement
  • CBO Cost Estimates [1]

Subject — Policy Area:

Summary: H.R.1492 — 115th Congress (2017-2018)All Information (Except Text)

Bill summaries are authored by CRS.

Shown Here:
Passed House without amendment (07/12/2017)

(This measure has not been amended since it was introduced. The expanded summary of the House reported version is repeated here.)

Medical Controlled Substances Transportation Act of 2017

(Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration to register practitioners (other than pharmacies) to transport controlled substances to and administer controlled substances in other states.

A registered practitioner must: be licensed, registered, or authorized to administer controlled substances in the other state; limit the duration of transport to 72 consecutive hours; and comply with recordkeeping requirements.